Patient characteristics in relation to thrombosis
. | Antiphospholipid syndrome . | . | . | |
---|---|---|---|---|
. | Absent . | Present . | P . | |
Patients with SLE, n | 143 | 33 | — | |
Patients with PAPS, n | — | 6 | — | |
Patients with LLD, n | 5 | 11 | — | |
Total | 148 | 50 | — | |
Female, n | 135 | 45 | .8970 | |
Median age, y | 33 | 35 | .267 | |
Thrombosis, n | 10 | 50 | < .0001 | |
Arterial thrombosis, n | 7 | 25 | < .0001 | |
Stroke | 3 | 16 | < .01 | |
Myocardial infarction | 3 | 2 | .8323 | |
Periferal artery | 3 | 4 | .5204 | |
Distal aorta | — | 2 | — | |
Retinal artery | — | 3 | — | |
Venous thrombosis, n | 6 | 32 | < .0001 | |
Deep venous thrombosis | 5 | 25 | < .0001 | |
Pulmonary embolism | 1 | 18 | < .001 | |
Thrombophlebitis | 2 | 5 | .3520 | |
Portal vein thrombosis | — | 1 | — |
. | Antiphospholipid syndrome . | . | . | |
---|---|---|---|---|
. | Absent . | Present . | P . | |
Patients with SLE, n | 143 | 33 | — | |
Patients with PAPS, n | — | 6 | — | |
Patients with LLD, n | 5 | 11 | — | |
Total | 148 | 50 | — | |
Female, n | 135 | 45 | .8970 | |
Median age, y | 33 | 35 | .267 | |
Thrombosis, n | 10 | 50 | < .0001 | |
Arterial thrombosis, n | 7 | 25 | < .0001 | |
Stroke | 3 | 16 | < .01 | |
Myocardial infarction | 3 | 2 | .8323 | |
Periferal artery | 3 | 4 | .5204 | |
Distal aorta | — | 2 | — | |
Retinal artery | — | 3 | — | |
Venous thrombosis, n | 6 | 32 | < .0001 | |
Deep venous thrombosis | 5 | 25 | < .0001 | |
Pulmonary embolism | 1 | 18 | < .001 | |
Thrombophlebitis | 2 | 5 | .3520 | |
Portal vein thrombosis | — | 1 | — |
Numbers are depicted as absolute number of patients. Students t test or Mann Whitney test was used to calculate differences between the 2 groups. — indicates 0.